Advanced Development of Nitazoxanide, Administered Alone or in Combination With Oseltamivir, for Treatment of Acute Uncomplicated Influenza Virus Infection in Adults and Pediatric Patients AT Least 12 Years of AGE
Contract Overview
Contract Amount: $70,748,205 ($70.7M)
Contractor: Romark Laboratories, L.C.
Awarding Agency: Department of Health and Human Services
Start Date: 2013-02-28
End Date: 2015-12-31
Contract Duration: 1,036 days
Daily Burn Rate: $68.3K/day
Official Description: IGF::OT::IGF ADVANCED DEVELOPMENT OF NITAZOXANIDE, ADMINISTERED ALONE OR IN COMBINATION WITH OSELTAMIVIR, FOR TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA VIRUS INFECTION IN ADULTS AND PEDIATRIC PATIENTS AT LEAST 12 YEARS OF AGE
Place of Performance
Location: Florida, 33607
State: Florida Government Spending